Analysts Raise Biotech Stock Price Targets One After Another, Expecting a Golden Age Over the Next 10 Years
Amid rising sales of new biosimilars and improved profitability, securities analysts are taking a more favorable view of domestic companies in the sector. As patent expirations for major biopharmaceuticals and the expansion of overseas sales networks are seen as opportunities for market growth, attention is turning to companies with production and supply capabilities. Investors should select companies based on product-level sales performance and business competitiveness.
If you are planning to add to your holdings in stocks with demonstrated growth potential, you can also consider ways to secure investment funds. Depending on the terms for your existing account and eligible stocks, a stock-backed loan can be one option for increasing your investment capacity. By considering the purchase amount, financing costs and repayment plan together, you can develop a specific dollar-cost averaging strategy aligned with the growth trajectory of companies you are watching.
With 22 years as the industry leader, HiStockLoan offers a range of stock financing products, including products with annual interest rates in the 5% range. It can be used not only to secure new investment funds but also to refinance existing credit or outstanding balance transactions on more favorable terms. As a result, it is attracting attention as an option for investors seeking to improve the efficiency of their fund management while maintaining access to investment opportunities.
[Visit the industry-leading HiStockLoan: https://www.hisl.co.kr]
- HiStockLoan: Industry-lowest interest rates in the 5% range for additional investment funds and refinancing credit or outstanding balance transactions!
HiStockLoan has launched a securities-linked credit product with industry-lowest interest rates in the 5% range, allowing investors to use stock-backed loans without undue burden. The product can be used to purchase stocks or refinance outstanding balance or credit transactions with securities firms. Investors can borrow up to four times their own capital, including their own capital, regardless of credit rating. Investors using the alternative trading system (NXT) can also use the product. Recently, securities firms have shortened the maturity of new credit loans from 180 days to 90 days, so investors concerned about the length of time they can use the funds may also want to consider refinancing through a stock-backed loan.
Investors who want to learn more about HiStockLoan's range of tailored products can contact the customer service center at 1566-5113 to speak with a professional counselor at any time, 24 hours a day, regardless of whether they qualify for a loan.
- Industry-lowest interest rates in the 5% range
- ETF trading available
- No. 1 in market share for 22 consecutive years; Korea First Brand Award winner for 17 consecutive years
- Real-time repayment of outstanding balance and credit transactions with securities firms
- Trading through the alternative trading system (NXT) available
- Reliable consultation quality guarantee program
* HiStockLoan Customer Service Center: 1566-5113
Visit: https://www.hisl.co.kr
Jusung Engineering, Celltrion, Korean Air, Hanwha Solutions, Hanmi Pharmaceutical
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
※ This content does not reflect the editorial direction of The Asia Business Daily, and the information provider bears all responsibility.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.